ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3237

Responsiveness and Its Magnitude in the 36-Item Short Form Health Survey and the Lupus Quality of Life Questionnaire in Patients with Active Disease

Stephanie Nantes1, Jiandong Su2 and Zahi Touma3, 1University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 3Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: measure, Quality of life and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Wednesday, November 16, 2016

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment VI: Quality of Life

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: SF-36 and LupusQoL are Health-Related Quality-of-Life (HRQoL) questionnaires used in SLE. We determined: (1) concurrent construct validity of SF-36 and LupusQoL against disease activity in patients with moderate-to-severely active lupus and (2) intra-individual responsiveness and its magnitude for both questionnaires’ domains.  

Methods:  99 active SLE patients [SLEDAI-2K ≥6] were recruited from a single centre. Patients completed both questionnaires at baseline and follow-up visits. Questionnaires’ domains scores were correlated with SLEDAI-2K and evaluated for floor/ceiling effects. Anchors for responsiveness were defined by: 1-Minimal Clinically Important Difference (MCID) definitions of SF-36, 2-MCID of LupusQoL and 3- SLEDAI-2K. Each of these anchors grouped patients as improved, same, or worsened. The magnitude of change was measured with Standardized Response Means (SRMs).  

Results: In the 99 patients, SLEDAI-2K was 7.7±5.2 at baseline and 6.5±4.8 on follow-up at 4.7±3.1 months. SLEDAI-2K did not correlate with questionnaires’ domains confirming that HRQoL is an independent domain not associated with disease activity. Correlations among “comparable” domains of both questionnaires ranged from 0.70-0.79. Floor effect was present in 2 SF-36 domains (Role Emot, Role Phys). Ceiling effect was present in 4 SF-36 domains (Bod Pain, Role Emot, Role Phys, Social Funct) and 3 LupusQoL domains (Pain, Planning, Intimate Relat).   The number of patients with worsening/improvement in the domains of SF-36 and LupusQoL is represented in table 1. The magnitude of change (SRM) for all domains were small when SLEDAI-2K was an anchor and large when MCID of SF-36 or LupusQoL were anchors (Figure 1 and 2). Responsiveness of SF-36 and LupusQoL using SLEDAI-2K as an anchor (47% patients improved and 16% worsened) was small (SRMs ranged -0.3–+0.3).  

Conclusion: In active lupus patients, both SF-36 and LupusQoL are responsive to change with large SRMs in improving and worsening patients. Lupus-specific domains in LupusQoL (planning, burden to others, body image and intimate relationships) showed large SRMs. SF-36 and LupusQoL are acceptable questionnaires for monitoring HRQoL in patients with SLE.             Figure 1. Magnitude of change (SRMs) of SF-36 domains                 Figure 2. Magnitude of change (SRMs) of LupusQoL domains            


Disclosure: S. Nantes, None; J. Su, None; Z. Touma, None.

To cite this abstract in AMA style:

Nantes S, Su J, Touma Z. Responsiveness and Its Magnitude in the 36-Item Short Form Health Survey and the Lupus Quality of Life Questionnaire in Patients with Active Disease [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/responsiveness-and-its-magnitude-in-the-36-item-short-form-health-survey-and-the-lupus-quality-of-life-questionnaire-in-patients-with-active-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/responsiveness-and-its-magnitude-in-the-36-item-short-form-health-survey-and-the-lupus-quality-of-life-questionnaire-in-patients-with-active-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology